
David Fidei
Examiner (ID: 6483)
| Most Active Art Unit | 3728 |
| Art Unit(s) | 1775, 2404, 3788, 3208, 3728, 2401, 2899 |
| Total Applications | 3497 |
| Issued Applications | 2707 |
| Pending Applications | 110 |
| Abandoned Applications | 680 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18376244
[patent_doc_number] => 20230151327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => RETINAL ORGANOID MODEL SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 17/820488
[patent_app_country] => US
[patent_app_date] => 2022-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8959
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17820488
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/820488 | RETINAL ORGANOID MODEL SYSTEMS | Aug 16, 2022 | Pending |
Array
(
[id] => 19998445
[patent_doc_number] => 20250136667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-01
[patent_title] => ISOLATION OF THERAPEUTIC PROTEIN
[patent_app_type] => utility
[patent_app_number] => 18/681252
[patent_app_country] => US
[patent_app_date] => 2022-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5563
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18681252
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/681252 | ISOLATION OF THERAPEUTIC PROTEIN | Aug 4, 2022 | Pending |
Array
(
[id] => 18242283
[patent_doc_number] => 20230074594
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => GENOME EDITING USING CRISPR IN CORYNEBACTERIUM
[patent_app_type] => utility
[patent_app_number] => 17/817223
[patent_app_country] => US
[patent_app_date] => 2022-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20281
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17817223
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/817223 | GENOME EDITING USING CRISPR IN CORYNEBACTERIUM | Aug 2, 2022 | Abandoned |
Array
(
[id] => 18003563
[patent_doc_number] => 20220362329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => TREATING ACUTE LIVER DISEASE WITH TLR-MIK INIHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/875551
[patent_app_country] => US
[patent_app_date] => 2022-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31608
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17875551
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/875551 | TREATING ACUTE LIVER DISEASE WITH TLR-MIK INIHIBITORS | Jul 27, 2022 | Abandoned |
Array
(
[id] => 19256879
[patent_doc_number] => 12016908
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-25
[patent_title] => Compositions and methods for treating hemoglobinopathies
[patent_app_type] => utility
[patent_app_number] => 17/815128
[patent_app_country] => US
[patent_app_date] => 2022-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 76
[patent_figures_cnt] => 74
[patent_no_of_words] => 101236
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 212
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17815128
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/815128 | Compositions and methods for treating hemoglobinopathies | Jul 25, 2022 | Issued |
Array
(
[id] => 18020908
[patent_doc_number] => 20220372407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => Detergent Compositions and Uses of the Same
[patent_app_type] => utility
[patent_app_number] => 17/814679
[patent_app_country] => US
[patent_app_date] => 2022-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18274
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17814679
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/814679 | Detergent Compositions and Uses of the Same | Jul 24, 2022 | Abandoned |
Array
(
[id] => 18005371
[patent_doc_number] => 20220364137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => METHODS FOR INCREASING MANNOSE CONTENT OF RECOMBINANT PROTEINS
[patent_app_type] => utility
[patent_app_number] => 17/867602
[patent_app_country] => US
[patent_app_date] => 2022-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11140
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17867602
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/867602 | METHODS FOR INCREASING MANNOSE CONTENT OF RECOMBINANT PROTEINS | Jul 17, 2022 | Abandoned |
Array
(
[id] => 18237656
[patent_doc_number] => 20230069966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => HARVEST OPERATIONS FOR RECOMBINANT PROTEINS
[patent_app_type] => utility
[patent_app_number] => 17/864255
[patent_app_country] => US
[patent_app_date] => 2022-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12079
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17864255
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/864255 | HARVEST OPERATIONS FOR RECOMBINANT PROTEINS | Jul 12, 2022 | Abandoned |
Array
(
[id] => 19410583
[patent_doc_number] => 12076375
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-03
[patent_title] => Treating and preventing
[patent_app_type] => utility
[patent_app_number] => 17/812359
[patent_app_country] => US
[patent_app_date] => 2022-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 14623
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 210
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17812359
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/812359 | Treating and preventing | Jul 12, 2022 | Issued |
Array
(
[id] => 18530233
[patent_doc_number] => 20230235303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => METHODS FOR PURIFICATION OF ARYLSULFATASE A
[patent_app_type] => utility
[patent_app_number] => 17/810396
[patent_app_country] => US
[patent_app_date] => 2022-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29981
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17810396
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/810396 | Methods for purification of arylsulfatase A | Jun 30, 2022 | Issued |
Array
(
[id] => 18352046
[patent_doc_number] => 20230140157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => PLANT LECTINS AS CARRIERS OF ASSOCIATED DRUG SUBSTANCES INTO ANIMAL AND HUMAN CELLS
[patent_app_type] => utility
[patent_app_number] => 17/807544
[patent_app_country] => US
[patent_app_date] => 2022-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15183
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17807544
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/807544 | Plant lectins as carriers of associated drug substances into animal and human cells | Jun 16, 2022 | Issued |
Array
(
[id] => 17911345
[patent_doc_number] => 20220313740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => CELL PREPARATION FOR EXTEMPORANEOUS USE, USEFUL FOR HEALING AND REJUVENATION IN VIVO
[patent_app_type] => utility
[patent_app_number] => 17/837825
[patent_app_country] => US
[patent_app_date] => 2022-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18629
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17837825
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/837825 | CELL PREPARATION FOR EXTEMPORANEOUS USE, USEFUL FOR HEALING AND REJUVENATION IN VIVO | Jun 9, 2022 | Pending |
Array
(
[id] => 17945777
[patent_doc_number] => 20220332794
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => CELL CULTURE MEDIA CONTAINING COMBINATIONS OF PROTEINS
[patent_app_type] => utility
[patent_app_number] => 17/834026
[patent_app_country] => US
[patent_app_date] => 2022-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48356
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17834026
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/834026 | Cell culture media containing combinations of proteins | Jun 6, 2022 | Issued |
Array
(
[id] => 19667769
[patent_doc_number] => 12180502
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-31
[patent_title] => Nucleic acid-guided nucleases
[patent_app_type] => utility
[patent_app_number] => 17/829316
[patent_app_country] => US
[patent_app_date] => 2022-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 31
[patent_no_of_words] => 38475
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17829316
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/829316 | Nucleic acid-guided nucleases | May 30, 2022 | Issued |
Array
(
[id] => 17867468
[patent_doc_number] => 20220290204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => CELL CULTURE METHOD, ANTIBODY PRODUCTION METHOD, ORGANIC ACID REMOVAL METHOD, AND ANTIBODY
[patent_app_type] => utility
[patent_app_number] => 17/826545
[patent_app_country] => US
[patent_app_date] => 2022-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18078
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17826545
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/826545 | CELL CULTURE METHOD, ANTIBODY PRODUCTION METHOD, ORGANIC ACID REMOVAL METHOD, AND ANTIBODY | May 26, 2022 | Pending |
Array
(
[id] => 17807786
[patent_doc_number] => 20220259621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => NANOPARTICLE BIOHYBRID COMPLEXES
[patent_app_type] => utility
[patent_app_number] => 17/734809
[patent_app_country] => US
[patent_app_date] => 2022-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8302
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17734809
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/734809 | NANOPARTICLE BIOHYBRID COMPLEXES | May 1, 2022 | Abandoned |
Array
(
[id] => 17807441
[patent_doc_number] => 20220259276
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => VGLL4 WITH UCP-1 CIS-REGULATORY ELEMENT AND METHOD OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/731201
[patent_app_country] => US
[patent_app_date] => 2022-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12612
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17731201
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/731201 | Vgll4 with Ucp-1 cis-regulatory element and method of use thereof | Apr 26, 2022 | Issued |
Array
(
[id] => 19291821
[patent_doc_number] => 12031169
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-09
[patent_title] => Compounds, compositions, and methods for recovering water-immiscible compounds from microbial biomass
[patent_app_type] => utility
[patent_app_number] => 17/728978
[patent_app_country] => US
[patent_app_date] => 2022-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 15361
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17728978
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/728978 | Compounds, compositions, and methods for recovering water-immiscible compounds from microbial biomass | Apr 24, 2022 | Issued |
Array
(
[id] => 17982910
[patent_doc_number] => 20220348946
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => CHLOROPHYTE ALGAE HAVING IMPROVED PRODUCTIVITY
[patent_app_type] => utility
[patent_app_number] => 17/727588
[patent_app_country] => US
[patent_app_date] => 2022-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14187
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17727588
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/727588 | CHLOROPHYTE ALGAE HAVING IMPROVED PRODUCTIVITY | Apr 21, 2022 | Pending |
Array
(
[id] => 17982905
[patent_doc_number] => 20220348941
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => GENETICALLY MODIFIED RECOMBINANT CELL LINES
[patent_app_type] => utility
[patent_app_number] => 17/726324
[patent_app_country] => US
[patent_app_date] => 2022-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14821
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17726324
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/726324 | GENETICALLY MODIFIED RECOMBINANT CELL LINES | Apr 20, 2022 | Pending |